Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical…
Rakovina Therapeutics Announces Upsized Financing Up to $2.0 Million
Proposed $1.0 Million Convertible Debenture and Warrant Financing and Concurrent Common Share Private…
Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment
NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting
SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx),…
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB)…
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
February 20, 2026 09:05 ET | Source: Ernexa Therapeutics Inc. Live video…
Nokia Corporation – Managers’ transactions (Heard)
February 20, 2026 09:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions20…
Nokia Corporation – Managers’ transactions (Fisk)
February 20, 2026 09:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions20…
Gainwell Technologies and Medicaid Leaders to Highlight how States are Navigating H.R. 1 Requirements
Panel discussion will share insights on verification modernization, data transformation, and community…
Candel Therapeutics Announces Proposed $100 Million Public Offering
NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel…
